Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
58.90
Dollar change
+1.06
Percentage change
1.82
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y5.86% Total Holdings66 Perf Week0.71%
SponsorJPMorgan Chase ETF Type Tagsequity Return% 3Y- AUM8.69M Perf Month-1.26%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter7.93%
Index- Average Maturity Tagsbiotechnology Return% 10Y 52W High59.69 -1.32% Perf Half Y15.10%
Index Weighting Commodity Type Tagspharmaceutical Return% SI 52W Low47.67 23.57% Perf YTD1.82%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.01% 0.23% Perf Year14.58%
Dividend TTM0.51 (0.87%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.47 Perf 3Y-
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)52.56 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.51 Perf 10Y-
Expense0.65% Growth/Value SMA20-0.07% Flows% 3Y Rel Volume0.28 Prev Close57.85
Inverse/Leveraged Market Cap SMA500.76% Flows% 5Y Avg Volume0.96K Price58.90
IPONov 02, 2023 Option/ShortNo / Yes SMA2009.86% Trades Volume267 Change1.82%
Jpmorgan Healthcare Leaders ETF seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.